Subscribe
ken-wolter-shutterstock-com-2-
Ken Wolter / Shutterstock.com
28 July 2015Americas

Medtronic asks US Supreme Court to vacate infringement ruling

Medical device manufacturer Medtronic has asked the US Supreme Court to vacate a lower court ruling that it indirectly infringed a patent covering a machine used during spinal surgery, citing the latest ruling in Commil USA v Cisco Systems.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
US Supreme Court grants Medtronic’s GVR petition
20 January 2016   The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive.


Editor's picks

Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024

Editor's picks

Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024

More on this story

Americas
US Supreme Court grants Medtronic’s GVR petition
20 January 2016   The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive.

More on this story

Americas
US Supreme Court grants Medtronic’s GVR petition
20 January 2016   The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive.

More features

Preventative IP for preventative pharma healthcare
Court denies Regeneron bid to halt copy of blockbuster eye drug
Interview: Klaus Grabinski, UPC Court of Appeal president
Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy